Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Xiaoyuan Huang, Ting Fan, Li Li, Xuanxuan Nian, Jiayou Zhang, Xuefen Gao, Wei Zhao, Wei Chen, Zhaoqing Zhang, Zhihao Yao, Xixin Han, Jinrong Shi, Ying Wang, Haihe Bian, Nianmin Shi, Xinguo Li, Kai Duan, Guohua Li & Xiaoming Yang. (2022) Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Yu Liang, Gao Jing-xia, Lei Ma, Li Ni, Ruan Chaolie, Jian Zhou & Liao Guo-yang. (2021) Immunogenicity and safety levels of inactivated quadrivalent influenza vaccine in healthy adults via meta-analysis. Human Vaccines & Immunotherapeutics 17:10, pages 3652-3661.
Read now
Read now
Young Kyung Kang, Hea Lin Oh, Jung Sub Lim, Jun Ah Lee, Yun Kyung Kim, Byung Wook Eun, Dae Sun Jo & Dong Ho Kim. (2019) Evaluation of the field-protective effectiveness of seasonal influenza vaccine among Korean children aged < 5 years during the 2014–2015 and 2015–2016 influenza seasons: a cohort study. Human Vaccines & Immunotherapeutics 15:2, pages 481-486.
Read now
Read now
Susanna Esposito. (2018) 100 years since the 1918 influenza pandemic. Human Vaccines & Immunotherapeutics 14:3, pages 504-507.
Read now
Read now
John S. Tregoning, Ryan F. Russell & Ekaterina Kinnear. (2018) Adjuvanted influenza vaccines. Human Vaccines & Immunotherapeutics 14:3, pages 550-564.
Read now
Read now
Articles from other publishers (7)
Marilou Kiely, Fazia Tadount, Ernest Lo, Manish Sadarangani, Shu Qin Wei, Ellen Rafferty, Caroline Quach & Shannon E MacDonald. (2023) Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials. Journal of Epidemiology and Community Health 77:12, pages 791-801.
Crossref
Crossref
Sunho Choe, Oxana Talanova, Sooyoun Shin, Olga Syrkina & Marion Fournier. (2023) Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea. Infectious Diseases and Therapy 12:6, pages 1715-1723.
Crossref
Crossref
Sookyung Lim, Xiaoling Li, Olga Syrkina & Marion Fournier. (2022) Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea. Infectious Diseases and Therapy 11:5, pages 2035-2043.
Crossref
Crossref
Alice Mannocci, Andrea Pellacchia, Rossella Millevolte, Manuela Chiavarini & Chiara de Waure. (2022) Quadrivalent Vaccines for the Immunization of Adults against Influenza: A Systematic Review of Randomized Controlled Trials. International Journal of Environmental Research and Public Health 19:15, pages 9425.
Crossref
Crossref
Stephanie Pepin, Martin Dupuy, Charissa Fay Corazon Borja-Tabora, May Montellano, Lulu Bravo, Jaime Santos, Jo-Anne de Castro, Doris Maribel Rivera-Medina, Clare Cutland, Miguel Ariza, Javier Diez-Domingo, Celia Diaz Gonzalez, Federico Martinón-Torres, Efimia Papadopoulou-Alataki, Maria Theodoriadou, Marie Pierre Kazek-Duret, Sanjay Gurunathan & Iris De Bruijn. (2019) Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6–35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres. Vaccine 37:13, pages 1876-1884.
Crossref
Crossref
José Antonio López Trigo, Rosa López Mongil, Alberto Mariano Lázaro, Gloria Mato Chaín, Norberto Moreno Villajos & Primitivo Ramos Cordero. (2018) Vacunación frente a la gripe estacional en las personas mayores. Evaluación de la vacuna tetravalente. Informe de posicionamiento. Revista Española de Geriatría y Gerontología 53, pages 185-202.
Crossref
Crossref
Emanuele Montomoli, Alessandro Torelli, Ilaria Manini & Elena Gianchecchi. (2018) Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults. Vaccines 6:1, pages 14.
Crossref
Crossref